Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriflunomide in patients with a first clinical episode suggestive of MS (TOPIC)
NCT00622700Phase 3Completed
- Sponsor
- Sanofi
- Start
- Feb 2008
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 21
01
Overview
A Phase 3 trial of teriflunomide in clinically isolated syndrome (CIS), sponsored by Sanofi. Started Feb 2008; status: completed.
02
Drugs
teriflunomide
03
Conditions
clinically isolated syndrome (CIS)
Beyond the preview
Go deeper on NCT00622700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00622700.